Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12116346
Human plasma kallikrein inhibitors
granted -
US 12116574
Anti-inflammatory treatment via inhibition of endothelial cell kinesin light chain 1, variant 1 (KLC1C)
granted -
US 12116461
Host-guest interactions for pa superstructure formation
granted -
US 12116589
Treatment of amyotrophic lateral sclerosis (ALS)
granted -
US 12116604
Transposase polypeptides and uses thereof
granted -
US 12115136
Fortified CBD oil for treatment of PTSD
granted -
US 12116596
Method and apparatus for improved mesenchymal stem cell harvesting
granted -
US 12116375
Compositions and methods for treating cancer
granted -
US 12116597
Autophagy as a therapeutic target for intracranial aneurysm
granted -
US 12116423
Ang (1-7) derivative oligopeptides and methods for using and producing the same
granted -
US 12116622
Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF
granted -
US 12116637
Compositions and methods for detecting and treating high grade subtypes of uterine cancer
granted -
US 12115198
Microbials for animals
granted -
US 12116635
Methods for detecting and treating cancers having adenosine pathway activation
granted -
US 12116606
Complement factor I-related compositions and methods
granted -
US 12115166
Corticotropin releasing factor receptor antagonists
granted -
US 12116405
Arthritis treatment
granted -
US 12115255
Methods of use of emulsion formulations of an NK-1 receptor antagonist
granted -
US 12116343
Inhibitors of APOL1 and methods of using same
granted -
US 12115183
Synthetic melanin nanoparticles and uses thereof
granted -
US 12116374
Solid forms of 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione
granted -
US 12115165
Use of reboxetine to treat narcolepsy
granted -
US 12115163
Combination therapy comprising a MAT2A inhibitor and a type II PRMT inhibitor
granted -
US 12115156
Compositions of CXCR4 inhibitors and methods of preparation and use
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.